ECL Ecolab Inc.

New Water Safety Program Helps Healthcare Providers Meet New Requirements to Reduce Legionella Risk

Nalco Water, an Ecolab company, has introduced a comprehensive water safety program to help hospitals and long-term care facilities meet new requirements to reduce Legionella risk. The program helps streamline the process to meet the current Survey and Certification (S&C) 17-30 requirements established by the Center for Clinical Standards and Quality under the Centers for Medicare and Medicaid Services.

Legionnaires’ disease, a severe and sometimes fatal pneumonia, can occur in people who inhale aerosolized droplets of water contaminated with the bacterium Legionella. Outbreaks have been linked to large or complex water systems in buildings such as hospitals and long-term care facilities.

Per the new S&C 17-30 requirements, all hospitals, critical-access hospitals and long-term care providers that participate in Medicare are required to take specific steps to reduce Legionella risk in their water systems.

“Healthcare providers are seeking a complete solution to meet the new S&C 17-30 requirements,” said Michael Johannsen, executive vice president and general manager of global light industries and water services. “Our water safety program for healthcare is designed to simplify the process to meet the standard and ensure ongoing compliance.”

Nalco Water’s water safety program for healthcare is an enterprise-level solution that streamlines management of water safety risk across multiple sites. It includes a professional risk assessment, development of an ASHRAE-188 compliant water safety plan, training, sampling and testing services, and an on-site emergency response plan.

The water safety program complements Ecolab’s broader healthcare programs, which are focused on the prevention of healthcare-associated infections and driving operational efficiency in acute care hospitals. These programs include offerings for operating room turnover, patient temperature management, hand hygiene and surgical instrument reprocessing and surface disinfectants with EPA-registered claims against pathogens including Clostridium difficile, methicillin-resistant Staphylococcus aureus, influenza and norovirus.

A charter member of the CDC-Elite proficiency program, Nalco Water conducts more than 80,000 Legionella tests annually. For more information about Nalco Water’s water safety plans and programs, visit www.ecolab.com/nalco-water or email [email protected].

About Nalco Water

Nalco Water, an Ecolab company, is the leading global provider of water management solutions and expertise to maximize operating performance and minimize water and energy use for industrial and institutional customers. Nalco Water’s broad suite of industry-leading technologies and advanced chemistries are designed to meet today’s complex water management needs.

About Ecolab

Nalco Water is an Ecolab company. A trusted partner at more than one million customer locations, Ecolab (ECL) is the global leader in water, hygiene and energy technologies and services that protect people and vital resources. With 2016 sales of $13 billion and 48,000 associates, Ecolab delivers comprehensive solutions and on-site service to promote safe food, maintain clean environments, optimize water and energy use and improve operational efficiencies for customers in the food, healthcare, energy, hospitality and industrial markets in more than 170 countries around the world. www.ecolab.com.

(ECL-P)

EN
08/08/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ecolab Inc.

Ecolab Inc.: Update to credit profile – Focus on faster growth

Our credit view of this issuer reflects is strong earnings growth, constrained by event risk related to acquisitions.

Ecolab Inc. - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's Ratings assigns A3 rating to Ecolab's new senior unsecured not...

Moody's Ratings (Moody's) assigned an A3 rating to Ecolab Inc.'s (Ecolab) new $500 million senior unsecured notes due in 2035. The net proceeds of the notes issuance will be used for general corporate purposes, including partial funding of the Ovivo Electronics acquisition and repayment of indebtedn...

Ecolab Inc: 4 directors

Four Directors at Ecolab Inc sold after exercising options/bought/sold 9,625 shares at between 263.050USD and 264.692USD. The significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all...

Ecolab Inc.: Update to credit profile – Focus on faster growth

Our credit view of this issuer reflects its conservative leverage targets and excellent liquidity, constrained by its ongoing efforts to improve lower margin healthcare business.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch